Thrombosis at the crossroads of inflammation, coagulation, and vascular biology: Recent advances and emerging therapeutic strategies

Thrombosis is a multifaceted pathological process involving intravascular clot formation that drives a range of cardiovascular and cerebrovascular diseases, including myocardial infarction, ischemic stroke, venous thromboembolism, and cancer-associated thrombosis. Despite major advances in anticoagulation and thrombolytic therapies, clinical outcomes remain limited by bleeding risk, incomplete clot dissolution, and variable patient response. Emerging evidence increasingly portrays thrombosis as a dynamic immunoinflammatory disorder, integrating coagulation, inflammation, and immune signaling into what is collectively termed thrombo-inflammation. Mechanistic insights have uncovered crucial roles for neutrophil extracellular traps (NETs), platelet-leukocyte interactions, complement activation, and metabolites derived from gut microbiota in facilitating the formation and persistence of thrombi. Translational research has mirrored this trend, with the development of innovative therapeutics such as Factor XI/XII inhibitors, RNA-based agents, and nanocarrier-guided delivery systems. These are crafted to precisely modulate antithrombotic efficacy while ensuring the preservation of hemostatic balance. At the same time, advancements in thrombolytic techniques, such as clot-sensitive fibrinolytics and interventions using ultrasound assistance and catheter guidance, provide treatment options focused on precision. Advances in diagnostic platforms, including artificial intelligence (AI) -enhanced imaging, microfluidic assays, and multi-omics biomarker profiling, are further transforming early detection and individualized risk stratification. This review brings together current molecular and translational insights to map out the evolving paradigm of thrombosis as a systemic, multifactorial process. It emphasizes the emerging connections among bioengineering, omics-based profiling, and artificial intelligence, showcasing their combined potential to revolutionize prevention, diagnosis, and treatment strategies. By integrating these multidimensional perspectives, this review aims to chart the path toward precision thrombosis medicine and mechanism-targeted therapeutic innovation.

Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.

El resumen se deja sin traducir para conservar la redacción original de los autores.

This review positions thrombosis as a thrombo-inflammatory process driven by neutrophil extracellular traps, platelet-leukocyte interactions, complement, and microbiota-derived metabolites. It also covers new therapeutics such as factor XI/XII inhibitors, RNA-based agents, and nanocarrier delivery, plus AI-enhanced diagnostics for early detection and risk stratification.

Explore cómo esta investigación se conecta con la práctica clínica

Más estudios revisados por pares en la categoría «Ensayos clínicos».

• Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
• Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
• Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
• Investigación de los efectos terapéuticos del tratamiento con sanguijuelas medicinales sobre la lesión por isquemia-reperfusión de la extremidad inferior — Ünal K et al. (2026)
• Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
• HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
• Hirudoterapia en la cicatrización de heridas — Nair H et al. (2022)
• Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)

Ver toda la investigación analizada por la ASH →